Atrial Fibrillation
The MD Magazine Atrial Fibrillation condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

Latest Headlines

Stroke Risk Higher During Cold Weather for Patients with Atrial Fibrillation
New research suggests that cold weather may be an underappreciated hazard for patients with atrial fibrillation.
The first real-world study of its kind revealed that rivaroxaban, marketed as Xarelto, can reduce the risk of stroke and major bleeding in patients with atrial fibrillation (AF) – a group that is five times more likely to suffer a stroke compared to the general population.
As with all cardiac intervention procedures there are risks for the patients. However, working in consultation with doctors the results can be minimized to provide the best level of care.
The MANTRA-PAF trial, A study looking at a treatment for paroxysmal atrial fibrillation reached its five year follow-up mark and the results were shared at the recent European Society of Cardiology Congress to see whether surgical or pharmaceutical treatment was better for patients.
While the treatment of atrial fibrillation has made many advancements in recent years there is still much more work to be done. As with other areas of medicine this includes individualized approaches to care.

Most Popular

$vacMongoViewPlus$ $vAR$